Right after Novartis takes stake in proteomics company, it raises $16.5M
Just a few weeks after Novartis announced it’s taken an ownership stake in Colorado’s SomaLogic, the proteomics company has raised $16.5 million, according to a regulatory filing. Although SomaLogic’s keeping quiet on who’s invested and what it’s for, the company’s an early player in applying proteomics to the diagnostics field – and Novartis has a demonstrated interest in the field. […]